Article
The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia.
Blood - 15 Jul 2005
Oppezzo Pablo, Vasconcelos Yuri, Settegrana Catherine, Jeannel Dominique, Vuillier Françoise, Legarff-Tavernier Magali, Kimura Eliza Yuriko, Bechet Stéphane, Dumas Gérard, Brissard Martine, Merle-Béral Hélène, Yamamoto Mihoko, Dighiero Guillaume, Davi Frédéric
Abstract excerpt
Although the zeta-associated protein of 70 kDa (ZAP-70) is overexpressed in patients with chronic lymphocytic leukemia (CLL) displaying unmutated IGVH genes and poor prognosis, a previous microarray study from our group identified overexpression of LPL and ADAM29 genes among unmutated and mutated CLL, respectively. To assess the prognostic value of these genes, we quantified their expression by real-time...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
